These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25585680)

  • 21. Methods for mining HTS data.
    Harper G; Pickett SD
    Drug Discov Today; 2006 Aug; 11(15-16):694-9. PubMed ID: 16846796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The right combination.
    Nature; 2006 Jan; 439(7075):390-1. PubMed ID: 16437083
    [No Abstract]   [Full Text] [Related]  

  • 23. Animal intelligence.
    Hoag H
    Nature; 2006 May; 441(7092):544-5. PubMed ID: 16789060
    [No Abstract]   [Full Text] [Related]  

  • 24. The Japanese perspective regarding regulatory concerns for biotechnology drugs and their scientific basis.
    Hayakawa T
    Bioprocess Technol; 1991; 13():468-98. PubMed ID: 1367147
    [No Abstract]   [Full Text] [Related]  

  • 25. Harmonization of rules in GLP and pharmacokinetic analysis: regulatory view.
    Grabowski T; Marczak M; Muszynski M; Jaroszewski JJ
    Bioanalysis; 2012 Feb; 4(4):417-30. PubMed ID: 22394142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging technologies for prediction of drug candidate efficacy in the preclinical pipeline.
    Menshykau D
    Drug Discov Today; 2017 Nov; 22(11):1598-1603. PubMed ID: 28545837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing time for stem cells.
    Baker M
    Nature; 2010 Feb; 463(7282):719. PubMed ID: 20148005
    [No Abstract]   [Full Text] [Related]  

  • 28. Marine natural products: drugs from the deep.
    Marris E
    Nature; 2006 Oct; 443(7114):904-5. PubMed ID: 17066005
    [No Abstract]   [Full Text] [Related]  

  • 29. Removing obstacles in neuroscience drug discovery: the future path for animal models.
    Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
    Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-based versus isolated target screening: how lucky do you feel?
    Moore K; Rees S
    J Biomol Screen; 2001 Apr; 6(2):69-74. PubMed ID: 11689100
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug target identification: a question of biology.
    Smith C
    Nature; 2004 Mar; 428(6979):225-31. PubMed ID: 15014514
    [No Abstract]   [Full Text] [Related]  

  • 32. Developing PreDICT - a fully integrated data platform for preclinical in vivo data: learning from experience.
    Jones RDO; Cooke M; Hinchliffe J; Morley J; Barry ST
    Drug Discov Today; 2017 Oct; 22(10):1539-1546. PubMed ID: 28800878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Legacy data sharing to improve drug safety assessment: the eTOX project.
    Sanz F; Pognan F; Steger-Hartmann T; Díaz C; ; Cases M; Pastor M; Marc P; Wichard J; Briggs K; Watson DK; Kleinöder T; Yang C; Amberg A; Beaumont M; Brookes AJ; Brunak S; Cronin MTD; Ecker GF; Escher S; Greene N; Guzmán A; Hersey A; Jacques P; Lammens L; Mestres J; Muster W; Northeved H; Pinches M; Saiz J; Sajot N; Valencia A; van der Lei J; Vermeulen NPE; Vock E; Wolber G; Zamora I
    Nat Rev Drug Discov; 2017 Dec; 16(12):811-812. PubMed ID: 29026211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Neuroscience Peer Review Consortium.
    Saper CB
    Exp Neurol; 2009 Mar; 216(1):1-2. PubMed ID: 19217967
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of the LD50 test in the pharmaceutical industry.
    Dayan AD; Clark B; Jackson M; Morgan H; Charlesworth FA
    Lancet; 1984 Mar; 1(8376):555-6. PubMed ID: 6142263
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroprotective therapies: Preclinical reproducibility is only part of the problem.
    Tymianski M
    Sci Transl Med; 2015 Aug; 7(299):299fs32. PubMed ID: 26246165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational medicine 2006.
    Persiani S
    IDrugs; 2006 Apr; 9(4):253-5. PubMed ID: 16596476
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for success.
    Mahapatra A
    ACS Chem Biol; 2008 Aug; 3(8):449-50. PubMed ID: 18707052
    [No Abstract]   [Full Text] [Related]  

  • 39. Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective.
    Wong H; Bohnert T; Damian-Iordache V; Gibson C; Hsu CP; Krishnatry AS; Liederer BM; Lin J; Lu Q; Mettetal JT; Mudra DR; Nijsen MJMA; Schroeder P; Schuck E; Suryawanshi S; Trapa P; Tsai A; Wang H; Wu F
    Drug Discov Today; 2017 Oct; 22(10):1447-1459. PubMed ID: 28476536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of preclinical animal models in breast cancer drug development.
    Clarke R
    Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S22. PubMed ID: 20030874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.